a highly selective protein phosphatase 2B inhibitor; structure in first source Heading Mapped to: Bridged Bicyclo Compounds, Heterocyclic
Norcantharidin has been studied across 15 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🫘 Kidney, ⚡ Energy & Fatigue, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 71% of studies addressing this area.
This evidence profile for Norcantharidin is generated deterministically from 294 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.